Sanjay S. Shukla

President & Chief Executive Officer, Director at aTyr Pharma, Inc.

Sanjay S. Shukla

Sanjay S. Shukla

President & Chief Executive Officer, Director at aTyr Pharma, Inc.

Biography

Sanjay S. Shukla occupies the position of President, Chief Executive Officer & Director at aTyr Pharma, Inc. In his past career Dr. Shukla occupied the position of Vice President & Head-Integrated Medical Services at Novartis AG. He received a graduate degree from the University of Maryland and a doctorate from Howard University College of Medicine.

Overview
Career Highlights

aTyr Pharma, Inc.

RelSci Relationships

1020

Number of Boards

1

Birthday

1971

Age

48

Relationships
RelSci Relationships are individuals Sanjay S. Shukla likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at REPLIGEN Corp.

Relationship likelihood: Strong

Chief Executive Officer & Director at Gene Sciences, Inc.

Relationship likelihood: Strong

Co-Founder at Cardinal Partners

Relationship likelihood: Strong

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Former Vice President-Financial Services at California Healthcare Institute

Relationship likelihood: Strong

President & Chief Executive Officer at Dewpoint Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Zafgen, Inc.

Relationship likelihood: Strong

Director, Center for the Genetics of Host Defense at University of Texas Southwestern Medical Center - Center for the Genetics of Host Defense

Relationship likelihood: Strong

Chief Financial & Accounting Officer at aTyr Pharma, Inc.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Paths to Sanjay S. Shukla
Potential Connections via
Relationship Science
You
Sanjay S. Shukla
President & Chief Executive Officer, Director at aTyr Pharma, Inc.
Education

The University of Maryland, College Park is a public research university, the flagship campus of the University System of Maryland, and the original 1862 land-grant institution in the State. The University of Maryland is committed to achieving excellence as the State’s primary center of research and graduate education and the institution of choice for undergraduate students of exceptional ability and promise. The University creates and applies knowledge for the benefit of the economy and culture of the State, the region, the nation, and beyond. As the flagship of the University System of Maryland, the University shares its research, educational, cultural, and technological strengths with businesses, government, and other educational institutions. The University counts among its greatest strengths -- and a major component of its excellence -- the diversity of its faculty, students, and staff. The University of Maryland, College Park is committed to equal educational opportunity and strives to hire a diverse faculty and staff of exceptional achievement through affirmative actions, to celebrate diversity in all of its programs and activities, and to recruit and retain qualified graduate and undergraduate minority students.

Howard University College of Medicine is a school in Washington.

Career History
President & Chief Executive Officer, Director
2016 - Current

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Vice President & Head-Integrated Medical Services
2012 - 2015

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Transactions
Details Hidden

aTyr Pharma, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Sanjay S. Shukla is affiliated with aTyr Pharma, Inc., Novartis AG

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sanjay S. Shukla. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sanjay S. Shukla's profile does not indicate a business or promotional relationship of any kind between RelSci and Sanjay S. Shukla.